Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Jul 14, 2021
Jun 26, 2021
Jun 14, 2021
Events
Jun 9, 2021 at 12:00 PM PDT
May 12, 2021 at 8:00 AM PDT
SEC Filings
| Filing date | Description | Form |
|---|---|---|
Annual report which provides a comprehensive overview of the company for the past year |
10-K | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q | |
Initial filing by director officer or owner of more than ten percent. |
3 |